Earlier quoted context omitted.
A key determiner is who invents an effective treatment and vaccine first. Many bright young minds globally are paying great attention to Covid-19. If it happens in a country, possibly US, East Asia, or Europe, then the institutions of higher learning in the country would gain immediate prestige. (Pretty sure some teams in China have set its sight on this.) If it happens in East Asia, that would also be a recognition…
I agree with the last part of your statement, but not the first. By the time an effective vaccine is developed and run through human trials, most of the population will already have gotten Covid, so it's not likely to be a savior moment. Additionally, given how many vaccine candidates are already in the pipeline, it's pretty likely there will be multiple options approved within a few months of each other. On a relate…
If a vaccine developed in East Asia is either cheaper, more scalable, or more effective, increased self-confidence would mean many top students will choose to pursue graduate studies at home instead of the US. This is in addition to fear of being discriminated against because of the pandemic.
Given the number of top people in East Asia with strong quantitative skills, it would significantly shift research momentum to the east.